WEDNESDAY, JULY 18, 2018

Aeras

1405 Research Blvd
Rockville, MD 20850

Aeras News

ABIVAX to market typhoid, other vaccines in Asian and Latin American markets

ABIVAX signed an agreement with The Finlay Institute in Havana, Cuba, on Wednesday to commercialize vaccines against typhoid, meningococcus and leptospirosis in Asian and Latin American markets. Read More »

New study has possible explanation why yellow fever mosquitoes favor human blood

The deadly yellow fever mosquito is more attracted to human odor due to a genetic change not present in its ancestors. Read More »

Diarrhea bacteria genome decoded; vaccine in the works

Researchers at the University of Gothenburg's Sahlgrenska Academy have determined the genetic composition of the bacteria that cause diarrhea and can now create a vaccine. Read More »

Studies seek more effective Ebola diagnosis methods

Scientists recently conducted studies to determine how to diagnose hemorrhagic fevers more efficiently before individuals show symptoms. Read More »

GenVec shares data from its study of the GV2311 vaccine

GenVec, Inc. publicly shared its data concerning immune responses to its latest vaccine, GV2311. Read More »

Aethlon's Hemopurifier therapy reportedly cures Ebola patient

Aethlon Medical, a main developer of targeted therapeutic devices for infectious diseases and cancer, diagnosed and cured an Ebola patient using Hemopurifier therapy, a newspaper has reported. Read More »

Study on mosquitoes' preferred gender to feed on may help limit disease transmission

In a recent online article published in Royal Society Open Science, it has been determined by University of Florida research that mosquitoes bite male birds nearly twice as often as they bite female birds. Read More »

Study: Google searches can provide accurate flu forecasts

Internet search terms really do provide a more accurate real-time forecast of current flu infections, researchers at the University of Warwick recently found. Read More »

DoD awards Profectus Biosciences $9.5M to create Ebola/Marburg vaccine

The U.S. Department of Defense (DoD) will provide $9.5 million in funding to Profectus BioSciences Inc., for the manufacture and preclinical testing of the Profectus trivalent Ebola/Marburg vaccine. Read More »

Health professionals heighten awareness against measles

In an editorial from the New England Journal of Medicine, experts from Emory Vaccine Center urged health professionals to focus more on measles outbreaks. Read More »

Egg-free Flublok flu vaccine now available to all adults

The U.S. Read More »

St. Louis researchers sequence enterovirus D68 genome

Scientists and researchers at Washington University School of Medicine in St. Louis have sequenced this week the genome of enterovirus D68 taken from patients treated recently at St. Louis Children's Hospital. Read More »

Worldwide tuberculosis cases declining

Although a new report by the World Health Organization (WHO) showed that multidrug-resistant tubercolosis (MDR TB) had infected 480,000 people worldwide in 2013, the overall number of TB cases is slowly declining. Read More »

New TB guidelines put in place by the World Health Organization

As part of its Post-2015 Global Tuberculosis Strategy (End TB), the World Health Organization announced new guidelines on Tuesday for the treatment of TB. Read More »

Discovery aids herpes research; two drugs recommended for patients

In light of new research showing a protective layer covering herpes viruses, the Center for the Biology of Chronic Disease (CBCD) has publicized two natural remedy recommendations. Read More »

Discovery could lead to better HIV treatment options

The recent discovery of the new protein Ssu72 by researchers at the Salk Institute could lead to advancements in how the human immunodeficiency virus (HIV) is treated. Read More »

Study finds mosquito gut bacterium could help prevent malaria, dengue fever

A study published in PLOS Pathogens on Thursday found that the Chromobacterium sp. (Csp_P) bacterium from the gut of an Aedes mosquito has the ability to reduce malaria and dengue infection in other mosquitoes. Read More »

Entervirus D68 expected to fade with colder temperatures

Experts have reassured the public that the number of particularly severe Enterovirus D68 (EV-D68) cases will decrease with coming winter temperatures. Read More »

Profectus and GNL receive $8.5 million Army grant for vaccine development

Profectus BioSciences, Inc. and the Galveston National Laboratory (GNL) at the University of Texas Medical Branch at Galveston (UTMB) have received a three-year, $8.5 million grant from the Department of the Army, U.S. Read More »

Johnson & Johnson on fast track to develop new Ebola vaccine

Johnson & Johnson has made a commitment of up to $200 million to fast-track an Ebola vaccine currently in development at its Janssen Pharmaceutical Companies. Read More »